310 related articles for article (PubMed ID: 30402813)
1. [Immunotherapy highlights of the ASCO annual meeting 2018 for head and neck cancers].
Laban S; Doescher J; Busch CJ; Wollenberg B; Dietz A; Würdemann N; Schuler PJ; Hoffmann TK
HNO; 2018 Dec; 66(12):880-887. PubMed ID: 30402813
[TBL] [Abstract][Full Text] [Related]
2. [Immunotherapy of head and neck tumors: Highlights of the ASCO Meeting 2015].
Laban S; Doescher J; Schuler PJ; Bullinger L; Brunner C; Veit JA; Hoffmann TK
HNO; 2015 Sep; 63(9):612-9. PubMed ID: 26319429
[TBL] [Abstract][Full Text] [Related]
3. [Immunotherapy for head and neck cancer : Highlights of the 2019 ASCO Annual Meeting].
Doescher J; Busch CJ; Wollenberg B; Dietz A; Würdemann N; Schuler P; Hoffmann TK; Laban S
HNO; 2019 Dec; 67(12):905-911. PubMed ID: 31612261
[TBL] [Abstract][Full Text] [Related]
4. [Immunotherapeutic studies of head and neck tumors : Highlights of the 2016 ASCO Annual Meeting].
Busch CJ; Laban S; Knecht R; Hoffmann TK
HNO; 2016 Oct; 64(10):708-16. PubMed ID: 27604282
[TBL] [Abstract][Full Text] [Related]
5. [Radiotherapeutic studies of head and neck cancer-highlights of the 2018 ASCO Annual Meeting].
Ott S; Wiegel T; Laban S; Hoffmann TK; Petersen C; Tribius S
HNO; 2018 Dec; 66(12):901-906. PubMed ID: 30421001
[TBL] [Abstract][Full Text] [Related]
6. [Trials in head and neck cancer - Highlights of the ASCO Annual Meeting 2021].
Wiegand S; Wichmann G; Dietz A
Laryngorhinootologie; 2021 Oct; 100(10):774-780. PubMed ID: 34470062
[TBL] [Abstract][Full Text] [Related]
7. [Immuno-, radio-, and chemotherapeutic studies in head and neck cancer : Highlights of the ASCO Annual Meeting 2017].
Schuler PJ; von Witzleben A; Doescher J; Wollenberg B; Dietz A; Hoffmann TK
HNO; 2018 Mar; 66(3):212-218. PubMed ID: 29460015
[TBL] [Abstract][Full Text] [Related]
8. Current studies of immunotherapy in head and neck cancer.
Dogan V; Rieckmann T; Münscher A; Busch CJ
Clin Otolaryngol; 2018 Feb; 43(1):13-21. PubMed ID: 28464441
[TBL] [Abstract][Full Text] [Related]
9. Immunotherapy of head and neck cancer: Emerging clinical trials from a National Cancer Institute Head and Neck Cancer Steering Committee Planning Meeting.
Bauman JE; Cohen E; Ferris RL; Adelstein DJ; Brizel DM; Ridge JA; O'Sullivan B; Burtness BA; Butterfield LH; Carson WE; Disis ML; Fox BA; Gajewski TF; Gillison ML; Hodge JW; Le QT; Raben D; Strome SE; Lynn J; Malik S
Cancer; 2017 Apr; 123(7):1259-1271. PubMed ID: 27906454
[TBL] [Abstract][Full Text] [Related]
10. [Studies on radiotherapy of head and neck cancer : Highlights of the 2019 ASCO Annual Meeting].
Ott S; Wiegel T; Hoffmann TK; Petersen C; Tribius S; Laban S
HNO; 2019 Dec; 67(12):918-924. PubMed ID: 31659379
[TBL] [Abstract][Full Text] [Related]
11. [Immunotherapy in the context of other head and neck cancer treatment modalities-highlights of the ASCO and ESMO annual meeting 2022].
von Witzleben A; Hoffmann TK; Laban S
HNO; 2023 Jul; 71(7):440-445. PubMed ID: 36941386
[TBL] [Abstract][Full Text] [Related]
12. [Study results of primary therapy for head and neck tumors : Highlights of the 2016 ASCO Annual Meeting].
Gliese A; Busch CJ; Knecht R
HNO; 2016 Oct; 64(10):717-22. PubMed ID: 27624903
[TBL] [Abstract][Full Text] [Related]
13. [The most important study results of primary chemoradiation for head and neck squamous cell carcinoma : highlights of the ASCO Meeting 2013].
Münscher A; Busch CJ; Schafhausen P; Tribius S; Knecht R
HNO; 2013 Nov; 61(11):905-10. PubMed ID: 24221218
[TBL] [Abstract][Full Text] [Related]
14. [Immunotherapy of head and neck cancer : Highlights of the ASCO and ESMO annual meetings 2021].
Theodoraki MN; Laban S; Hoffmann TK
HNO; 2022 Apr; 70(4):271-277. PubMed ID: 35037989
[TBL] [Abstract][Full Text] [Related]
15. [Immunotherapy for HNSCC : Quo vadis?].
Döscher J; Busch CJ; Schuler PJ; Laban S
HNO; 2016 Oct; 64(10):700-7. PubMed ID: 27624904
[TBL] [Abstract][Full Text] [Related]
16. Rationale for neoadjuvant immunotherapy in head and neck squamous cell carcinoma.
Hanna GJ; Adkins DR; Zolkind P; Uppaluri R
Oral Oncol; 2017 Oct; 73():65-69. PubMed ID: 28939078
[TBL] [Abstract][Full Text] [Related]
17. ASCO highlights podcast: head and neck cancers.
Merlano M
ESMO Open; 2016; 1(5):e000099. PubMed ID: 27843642
[TBL] [Abstract][Full Text] [Related]
18. [The most important results on primary chemoradiation for head and neck squamous cell carcinoma: highlights from the 2012 ASCO meeting].
Laban S; Zielinski V; Busch CJ; Münscher A; Schafhausen P; Tribius S; Knecht R
HNO; 2012 Nov; 60(11):962-7. PubMed ID: 23114542
[TBL] [Abstract][Full Text] [Related]
19. [Data from the 2022 ASCO Annual Meeting on surgical therapy].
Goncalves M; Duong Dinh TA; Hackenberg S
HNO; 2023 Jul; 71(7):431-439. PubMed ID: 37286710
[TBL] [Abstract][Full Text] [Related]
20. [Highlights from the 2021 ASCO and ESMO annual meetings on radiotherapy of head and neck cancer].
Hecht M; von der Grün J; Semrau S; Müller S; Weissmann T; Gaipl US; Iro H; Fietkau R; Gostian AO
HNO; 2022 Apr; 70(4):258-264. PubMed ID: 35294576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
